Trends of pharmaceutical corporations’ external innovation strategies: An inverse sigmoid curve-Reference-Cited by-同舟云学术

Trends of pharmaceutical corporations’ external innovation strategies: An inverse sigmoid curve

Published:2021-11 Issue: Volume:67 Page:101785
ISSN:0160-791X
Container-title:Technology in Society
language:en
Short-container-title:Technology in Society

Author:

Huang Jianan^ORCID

Publisher

Elsevier BV

Subject

Sociology and Political Science,Education,Business and International Management,Human Factors and Ergonomics

Reference16 articles.

1. Ensuring quality science from ‘R’ to ‘D’: an optimal adoption strategy for in-licensing of pharmaceutical innovation;Zhao;IEEE Trans. Eng. Manag.,2011

2. Economic considerations in cooperative research and development agreements (CRADA): the case of taxol, NIH, and technology transfer;Hemphill;Technol. Soc.,2006

3. Leveraging micro- and macro-structures of embeddedness in alliance networks for exploratory innovation in the pharmaceutical;Karamanos;R. Manag.,2012

4. How does external knowledge sourcing enhance product development? Evidence from drug commercialization;Moaniba;Technol. Soc.,2020

5. Helen boldon & brian warrington, “diagnosing the decline in pharmaceutical R&D efficiency”;Scannell;Nat. Rev. Drug Discov.,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How the interplay between innovation ecosystems and market contingency factors impacts startup innovation;Technology in Society;2024-03

2. Research landscape analysis for quality in Pharma 4.0 era;Technology in Society;2024-03

3. Diagnosing the declining industry sponsorship in clinical research;Scientometrics;2023-12-07

4. Drug licensing as evidence of evolution, diffusion and catch-up in East Asia;Nature Biotechnology;2023-02

5. How digital platform capability affects the innovation performance of SMEs—Evidence from China;Technology in Society;2023-02